| HOME >> BIOLOGY >> TECHNOLOGY |
Other long term debt 31.9 32.9
Deferred tax liability 338.1 332.4
Other non-current liabilities 388.0 375.6
_________ _________
Total non-current liabilities 1,858.0 1,840.9
_________ _________
Total liabilities 3,076.6 3,103.1
_________ _________
Unaudited US GAAP results for the three months to June 30, 2008
Consolidated Balance Sheets (continued)
June 30, December 31,
2008 2007
$M $M
_________ _________
Shareholders' equity:
Common stock of 5p par value; 1,000 million
shares authorized; and 559.9 million shares
issued and outstanding (2007: 750 million
shares authorized; and 553.2 million shares
issued and outstanding) 55.5 55.2
Exchangeable shares: nil shares issued and
outstanding (2007: 0.7 million) - 33.6
Treasury stock (19.6 million shares (380.5) (280.8)
(2007: 10.3 million shares))
Additional paid-in capital 2,563.9 2,503.4
Accumulated other comprehensive income 14.2 55.7
Accumulated deficit (1,126.9) (1,140.1)
_________ _________
Total shareholders' equity 1,1
'/>"/>
| SOURCE Shire Ltd Copyright©2008 PR Newswire. All rights reserved |